Projects per year
Personal profile
Biography
A/Prof. Ooi is an NHMRC Leadership Fellow and Head of the Regulatory T cell Therapies Groups at the School of Clinical Sciences.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Immunology
- Autoimmunity
- T-cell
Collaborations and top research areas from the last five years
-
Long Foundation Fellowship
Ooi, J. (Primary Chief Investigator (PCI))
8/12/24 → 4/02/28
Project: Research
-
Gastrointestinal-Restricted ALK5 Inhibitors for the Treatment of Intestinal Fibrosis
Flynn, B. (Primary Chief Investigator (PCI)), Goldberg, R. (Chief Investigator (CI)), Pitson, S. M. (Chief Investigator (CI)), Ooi, J. (Chief Investigator (CI)) & Rodent, K. K. (Chief Investigator (CI))
National Foundation for Medical Research and Innovation
1/03/24 → 1/09/25
Project: Research
-
Targeted regulatory T cells to treat autoimmune diseases
Ooi, J. (Primary Chief Investigator (PCI))
1/01/23 → 31/12/27
Project: Research
-
Targeted Regulatory T Cells to Treat SLE
Ooi, J. (Primary Chief Investigator (PCI)), Faridi, P. (Chief Investigator (CI)) & Morand, E. (Chief Investigator (CI))
United States Department of Defense (DOD), US Army Medical Research Acquisition Activity
1/09/22 → 31/08/25
Project: Research
-
Personalised T-cell receptor therapy for immunological "cold" cancers
Ho, G.-Y. (Primary Chief Investigator (PCI)), Faridi, P. (Chief Investigator (CI)), Nguyen, T. (Chief Investigator (CI)) & Ooi, J. (Chief Investigator (CI))
Project: Research
-
Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen
Eggenhuizen, P. J., Ng, B. H., Lo, C., Chang, J., Snelgrove, S. L., Cheong, R. M. Y., Shen, C., Lim, S., Zhong, Y., Gan, P. Y. & Ooi, J. D., Apr 2025, In: Kidney International. 107, 4, p. 751-756 6 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA
Gong, Y., Shen, C., Meng, T., Lin, W., Hu, X., Tang, R., Xiong, Q., Ooi, J. D., Eggenhuizen, P. J., Chen, J., Zhou, Y. O., Luo, H., Xu, J., Liu, N., Xiao, P., Xiao, X. & Zhong, Y., 2 Apr 2024, In: Clinical and Experimental Medicine. 24, 1, 66.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Epithelially Restricted Interferon Epsilon Protects Against Colitis
de Geus, E. D., Volaric, J. S., Matthews, A. Y., Mangan, N. E., Chang, J., Ooi, J. D., de Weerd, N. A., Giles, E. M. & Hertzog, P. J., 2024, In: Cellular and Molecular Gastroenterology and Hepatology. 17, 2, p. 267-278 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study
Gong, Y., Meng, T., Lin, W., Hu, X., Tang, R., Xiong, Q., Ooi, J. D., Eggenhuizen, P. J., Chen, J., Zhou, Y. O., Luo, H., Xu, J., Liu, N., Xiao, P., Xiao, X. & Zhong, Y., Sept 2024, In: Clinical Kidney Journal. 17, 9, 8 p., sfae264.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Smith-specific regulatory T cells halt the progression of lupus nephritis
Eggenhuizen, P. J., Cheong, R. M. Y., Lo, C., Chang, J., Ng, B. H., Ting, Y. T., Monk, J. A., Loh, K. L., Broury, A., Tay, E. S. V., Shen, C., Zhong, Y., Lim, S., Chung, J. X., Kandane-Rathnayake, R., Koelmeyer, R., Hoi, A., Chaudhry, A., Manzanillo, P. & Snelgrove, S. L. & 2 others, , 6 Feb 2024, In: Nature Communications. 15, 1, 14 p., 899.Research output: Contribution to journal › Article › Research › peer-review
Open Access19 Citations (Scopus)